accessibility menu, dialog, popup

UserName
Viewing profile as user:

Halomethanes

Organic compounds in which one or more of the hydrogens in methane is replaced with a halogen atom; halogen atoms include bromine, chlorine, fluorine, iodine.

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (1)
  • (15)
  • (8)

special interests

  • (16)

Search Within Results
Keyword Search:
1 – 15 of 24 results
1

Medchemexpress LLC 3-{[(3,4-dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid | 199735-88-1 | MFCD00167693 | >98.0% | 326.17 g·mol⁻¹ | C15H13Cl2NO3 | 50 MG
SDP

CADD522 is a small-molecule inhibitor of RUNX2-DNA binding used in research to downregulate RUNX2-mediated transcription. It has demonstrated antiproliferative and antimetastatic effects in cell-based and animal cancer studies and is supplied as a solid for laboratory use.

  • Inhibits RUNX2-DNA binding with reported IC50 ≈ 10 nM.
  • Demonstrated activity in in vitro and in vivo cancer models.
  • High purity appropriate for biochemical and cell-based assays.
  • Provided in small research quantities for screening and mechanistic studies.
  • Stable solid form; store at -20 °C under recommended conditions.

ENCOMPASS_PREFERRED
2

Medchemexpress LLC Tenuazonic acid | 610-88-8 | 5 MG
SDP

Tenuazonic acid is a nonhost-selective mycotoxin belonging to the tetramic acids family. It inhibits protein biosynthesis on ribosomes by suppressing the release of new protein. It is acutely toxic and functions as a photosystem II (PSII) inhibitor. Additionally, it exhibits antiviral effects on measles virus, enterovirus, and respiratory virus, and has an inhibitory effect on skin cancer.

  • Nonhost-selective mycotoxin
  • Belongs to the tetramic acids family
  • Inhibits protein biosynthesis on ribosomes
  • Blocks electron transport beyond the primary quinone receptor (QA)
  • Acts as a photosystem II (PSII) inhibitor
  • Has antiviral effects on measles virus, enterovirus, and respiratory virus
  • Has an inhibitory effect on skin cancer

ENCOMPASS_PREFERRED
3

Medchemexpress LLC TEPP-46-based aggregation-induced emission (AIE) probe | 2621957-88-6 | 99.4% | 544.6 g/mol | C27H20N4O5S2 | 10 MG
SDP

TEPC466 is an aggregation-induced emission (AIE) fluorescent probe based on TEPP-46, designed for selective detection and imaging of pyruvate kinase M2 (PKM2) in biological samples. It is used for cellular imaging applications and is supplied as a high-purity research chemical.

  • Selective detection of PKM2 via the AIE effect.
  • Suitable for cellular imaging applications.
  • High purity (99.43%) for reliable experimental results.
  • Molecular weight 544.6 g/mol; formula C27H20N4O5S2.
  • Multiple pack sizes available for experimental flexibility.
  • Accompanied by analytical documents such as COA, HNMR, LCMS, and RP-HPLC.

ENCOMPASS_PREFERRED
4

Medchemexpress LLC 2-Ethylbutyric acid | 88-09-5 | 116.16 | 500 MG
SDP

2-Ethylbutyric acid is a volatile fatty acid known for its phytotoxicity. It serves as an internal standard in milk and dairy products, aids in calibrating fecal VFA standards, and is used in embryonic development research.

  • Exhibits acute phytotoxicity in seed germination bioassays.
  • Shows teratogenic activity in pregnant mice at 600 mg/kg (s.c.; single dose).
  • No developmental toxicity in pregnant Sprague-Dawley rats at 150-200 mg/kg (p.o.; once daily; gestation days 6 to 15), with a No Observed Adverse Effect Level (NOAEL) of 200 mg/kg.
  • EC50 of 33.74 μM for reduction of propionyl-CoA in human hepatocytes.

ENCOMPASS_PREFERRED
5

eMolecules​ AstaTech / 2-IODOBENZENESULFONIC ACID MONOHYDRATE / 1g / 410713444 / CK2361 / 95.000 / 63059-25-6 / MFCD30534311 / 302.080 / C6H7IO4S

AstaTech / 2-IODOBENZENESULFONIC ACID MONOHYDRATE / 1g / 410713444 / CK2361 / 95.000 / 63059-25-6 / MFCD30534311 / 302.080 / C6H7IO4S

ENCOMPASS_PREFERRED
6

eMolecules​ AstaTech / 3-(METHYLCARBAMOYL)BENZENEBORONIC ACID / 1g / 448261347 / 26069 / 95.000 / 832695-88-2 / MFCD04038918 / 178.980 / C8H10BNO3

AstaTech / 3-(METHYLCARBAMOYL)BENZENEBORONIC ACID / 1g / 448261347 / 26069 / 95.000 / 832695-88-2 / MFCD04038918 / 178.980 / C8H10BNO3

ENCOMPASS_PREFERRED
7

eMolecules​ AstaTech / (S)-3-(CBZ-AMINO)BUTANOIC ACID / 0.25g / 308517972 / 62368 / 97.000 / 83509-88-0 / MFCD08277048 / 237.255 / C12H15NO4

AstaTech / (S)-3-(CBZ-AMINO)BUTANOIC ACID / 0.25g / 308517972 / 62368 / 97.000 / 83509-88-0 / MFCD08277048 / 237.255 / C12H15NO4

ENCOMPASS_PREFERRED
8

eMolecules​ ChemScene / 2-(2-(Benzyloxy)phenyl)acetic acid / 250mg / 632297018 / CS-0156164 / 0.000 / 22047-88-7 / MFCD00016822 / 242.274 / C15H14O3

ChemScene / 2-(2-(Benzyloxy)phenyl)acetic acid / 250mg / 632297018 / CS-0156164 / 0.000 / 22047-88-7 / MFCD00016822 / 242.274 / C15H14O3

ENCOMPASS_PREFERRED
9

eMolecules​ ChemScene / 3-(2-(Difluoromethoxy)phenyl)propanoic acid / 100mg / 794193835 / CS-0365521 / 0.000 / 1017030-88-4 / MFCD09951709 / 216.184 / C10H10F2O3

ChemScene / 3-(2-(Difluoromethoxy)phenyl)propanoic acid / 100mg / 794193835 / CS-0365521 / 0.000 / 1017030-88-4 / MFCD09951709 / 216.184 / C10H10F2O3

ENCOMPASS_PREFERRED
10

eMolecules​ ChemScene / (6-(Difluoromethoxy)pyridin-3-yl)boronic acid / 100mg / 632279945 / CS-0107244 / 0.000 / 1354290-88-2 / MFCD18261896 / 188.920 / C6H6BF2NO3

ChemScene / (6-(Difluoromethoxy)pyridin-3-yl)boronic acid / 100mg / 632279945 / CS-0107244 / 0.000 / 1354290-88-2 / MFCD18261896 / 188.920 / C6H6BF2NO3

ENCOMPASS_PREFERRED
11

eMolecules​ AstaTech / 1H-BENZO[D][123]TRIAZOLE-6-SULFONIC ACID / 0.25g / 444389076 / C16678 / 97.000 / 91159-88-5 / [null] / 199.180 / C6H5N3O3S

AstaTech / 1H-BENZO[D][123]TRIAZOLE-6-SULFONIC ACID / 0.25g / 444389076 / C16678 / 97.000 / 91159-88-5 / [null] / 199.180 / C6H5N3O3S

ENCOMPASS_PREFERRED
12

Medchemexpress LLC 3-((3,4-dichlorophenyl)carbamoyl)bicyclo[2.2.1]hept-5-ene-2-carboxylic acid | 199735-88-1 | MFCD00167693 | 98.2% | 326.17 g·mol⁻¹ | C15H13Cl2NO3 | 100 MG
SDP

CADD522 is a small-molecule inhibitor of RUNX2-DNA binding used for laboratory research. It downregulates RUNX2-mediated transcription, exhibits an IC50 of about 10 nM, and has shown inhibition of primary tumor growth and experimental metastasis in preclinical studies. Chemical identifiers include CAS 199735-88-1, formula C15H13Cl2NO3, and molecular weight 326.17 g·mol⁻¹.

  • High purity (98.2%).
  • Potent RUNX2-DNA binding inhibition (IC50 ≈ 10 nM).
  • Suitable for in vitro and preclinical research applications.
  • White to off-white solid, soluble in DMSO as a 10 mM solution.
  • Available as a 100 mg solid package.
  • For research use only; not for human or diagnostic use.

ENCOMPASS_PREFERRED
13

eMolecules​ Pharmablock / 1-(22-difluoro-2H-13-benzodioxol-5-yl)cyclopropane-1-carboxylic acid / 500mg / 551330895 / PBN20121188 / 0.000 / 862574-88-7 / MFCD13190001 / 242.178 / C11H8F2O4

Pharmablock / 1-(22-difluoro-2H-13-benzodioxol-5-yl)cyclopropane-1-carboxylic acid / 500mg / 551330895 / PBN20121188 / 0.000 / 862574-88-7 / MFCD13190001 / 242.178 / C11H8F2O4

ENCOMPASS_PREFERRED
14

Medchemexpress LLC 3-[4-[(7-hydroxy-6-methyl-2,3-dihydro-1H-inden-4-yl)methyl]-3,5-dimethylpyrazol-1-yl]propanoic acid | 1092551-88-6 | 99.9% | 328.41 | C19H24N2O3 | 25 MG
SDP

Omzotirome is a small-molecule thyromimetic research compound and a functional analog of iodothyronines investigated for antihyperlipidaemic activity. It is provided for laboratory research use in solid form or as a DMSO solution, with reported analytical data to support experimental work. Handle per institutional safety procedures and applicable regulations.

ENCOMPASS_PREFERRED
15

Medchemexpress LLC 2-Heptenoic acid, 7-[[1-[2-[(2-ethylbutyl)amino]-2-oxoethyl]-1,2-dihydro-2-oxo-3-pyridinyl]amino]-6-[[(1-me... | 1542132-88-6 | 100.0% | 528.60 | 5 MG
SDP

Vilagletistat (ZED-1227) is a specific and orally active transglutaminase 2 (TG2) inhibitor, with an IC50 of 45 nM. It effectively blocks inflammation-induced TG2 expression and activity, making it suitable for research into celiac disease (CeD).

  • Specific and orally active TG2 inhibitor
  • IC50 of 45 nM against TG2
  • Blocks inflammation-induced TG2 expression and activity
  • Suitable for research of celiac disease (CeD)
  • Shows no cytotoxic activity in Huh7 and CaCo2 cells
  • Inhibits TG2 in small intestinal mucosa both in vitro and in vivo

ENCOMPASS_PREFERRED